, 2004 and Suris et al., 2010) and reduce subjective and physiological measures of fear in phobic patients who were given glucocorticoids prior to exposure therapy (Soravia et al., 2006 and de Quervain

et al., 2011). Consistent with the broader role in memory enhancement, glucocorticoid administration prior to safety learning may later reduce anxiety and fear responses by bolstering initial extinction learning and consolidation within the amygdala and vmPFC. The precise mechanism underlying the immediate reduction of fear expression is less clear, but is thought to be related to glucocorticoids MDV3100 chemical structure impairing the retrieval of previously acquired aversive associations (de Quervain and Margraf, 2008). Interestingly, the therapeutic effects of glucocorticoids in these reports provided therapeutic benefits to anxiety patients only, indicating that glucorticoids may be most effective in patients suffering from stress-related buy 3-MA psychopathology. This is consistent with clinical research work showing that the hypersensitivity of glucocorticoids in PTSD

patients leads to reductions in basal cortisol levels (Yehuda, 2009). Therefore, anxiety populations may benefit from exogenous glucocorticoid administration because it promotes optimal glucocorticoid levels that lead to stronger inhibition of fear responses and more robust consolidation of safety learning.

When an aversive Idoxuridine outcome is imminent, cognitive strategies can be used to assert control over affective responses. These techniques—referred to as cognitive emotion regulation—are unique to humans and denote any regulatory strategy used intentionally to generate a more adaptive emotional response ( Gross, 1998 and Gross and Thompson, 2007). They include shifting attention away from aversive aspects of a stimulus, changing the meaning of a stimulus (i.e., reappraisal), or altering the expression of an emotional response (for reviews, see Gross and Thompson, 2007 and Gross, 2013). Recruiting cognitive strategies to deliberately change the way a stimulus is evaluated has been shown to effectively reduce the subjective ( Gross, 1998 and Shurick et al., 2012), physiological ( Gross and Thompson, 2007, Delgado et al., 2008 and Shurick et al., 2012) and neural components ( Ochsner et al., 2012, Hartley and Phelps, 2009 and Schiller and Delgado, 2010) of emotion. In humans, using cognitive control to change emotional responses is commonly used due it its unique capacity to be deployed at will in a variety of circumstances.